Lower, Monday?

Weeks of declining momentum for biotech XBI, may have culminated in an up thrust last Thursday

That push higher, led to Friday’s decline and new daily low (not advice, not a recommendation).

Recall, last time the ‘fundamentals’ were reviewed, seven of the of the top ten in market cap, had no P/E at all.

Biotech XBI, Weekly

Entire series: All-time highs-to-present.

Declining momentum, terminating wedge, ‘throw-over’.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279